$CIIX The Company's gross operating revenues for the fiscal year ended May 31, 2018, experienced a 41% year-over-year increase largely attributable to consumer product sales by the Company's subsidiaries, ChineseHempOil.com Inc. and CBD Biotechnology Co., Ltd. ("CBD Biotech").
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.